| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10920782 | Radiotherapy and Oncology | 2005 | 7 Pages |
Abstract
Inverse-planned HDR brachytherapy is a viable option to deliver higher dose to the prostate as a boost without increasing GU or rectal complication. Further HDR dose escalation to the prostate is feasible.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alireza Mahmoudieh, Christine Tremblay, Luc Beaulieu, Bernard Lachance, François Harel, Ãtienne Lessard, Jean Pouliot, Ãric Vigneault,